Intermittent explosive disorder-revised: Development, reliability, and validity of research criteria

Comprehensive Psychiatry

Volumn 39, Issue 6, 1998, Pages 368-376

  Coccaro, Emil F ^a   Kavoussi, Richard J ^b   Berman, Mitchell E ^b   Lish, Jennifer D ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGGRESSION; ARTICLE; BORDERLINE STATE; CLINICAL RESEARCH; DEMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY DISORDER; RATING SCALE; RELIABILITY; VALIDATION PROCESS;

EID: 0031785578     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(98)90050-5     Document Type: Article

References (47)

1. Maiuro RD. Intermittent explosive disorder. In: Dunner DL (ed): Current Psychiatric Therapy. Philadelphia, PA: Saunders, 1996.
2. Coccaro EF, Kavoussi RJ. Neurotransmitter correlates of impulsive aggression. In: Stoff DM, Cairns RB (eds): The Neurobiology of Clinical Aggression. Mahwah, NJ: Erlbaum, 1996:67-85.
3. Mattes JA, Fink M. A family study of patients with temper outbursts. J Psychiatr Res 1987;21:249-255.
4. Mattes JA, Fink M. A controlled family study of adopted patients with temper outbursts. J Nerv Ment Dis 1990;178:138-139.
5. Coccaro EF, Silverman J, Klar HM, Horvath TB, Siever LJ. Familial correlates of reduced central serotonergic system function in patients with personality disorder. Arch Gen Psychiatry 1994;51:318-324.
6. Plomin R, Nitz K, Rowe DC. Behavioral genetics and aggressive behavior in childhood. In: Lewis M, Miller S (eds): Handbook of Developmental Psychopathology. New York, NY: Plenum, 1990:119-133.
7. Coccaro EF, Bergeman CS, McClearn G. Heritability of irritable impulsiveness: A study of twins reared together and apart. Psychiatry Res 1993;48:229-242.
8. Coccaro EF, Bergeman CS, Kavoussi RJ, Seroczynski A. Heritability of aggression and irritability: A twin study of the Buss-Durkee aggression scales in adult male subjects. Biol Psychiatry 1997;41:273-284.
9. Coccaro EF, Siever LJ. The neuropsychopharmacology of personality disorder. In: Bloom F, Kupfer D (eds): Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven, 1995.
10. Linehan MM, Tutek DA, Heard HL, Armstrong HE. Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. Am J Psychiatry 1994; 151:1771-1776.
11. Sheard M, Marini J, Bridges C, Wapner A. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976;133:1409-1413.
12. Gardner DI, Cowdry RW. Positive effect of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 1986;143:519-522.
13. Fava M, Rosenbaum JF, Pava JA, McCarthy MK, Steingard RJ, Bouffides E. Anger attacks in unipolar depression, part 1: Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 1993;150:1158-1163.
14. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese, et al. Effect of fluoxetine on anger in symptomatic vounteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-29.
15. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry 1997;54:1081-1088.
16. Soloff PH, George A, Nathan RS, Schulz PM, Perel, JM. Paradoxical effects of amitriptyline in borderline patients. Am J Psychiatry 1986;143:1603-1605.
17. Gardner DI, Cowdry RW. Alprazolam-induced dyscontrol in borderline personality disorder. Am J Psychiatry 1985;142: 98-100.
18. Felthous AR, Bryant G, Wingerter CB, Barratt ES. The diagnosis of intermittent explosive disorder in violent men. Bull Amer Acad Psychiatry Law 1991;19:71-79.
19. Spitzer RL (ed). The Diagnostic and Statistical Manual-Third Edition. Revised (DSM-III-R). Washington, DC: American Psychiatric Press, 1987.
20. Coccaro EF, Siever LJ, Klar H, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in affective and personality disorder patients: Correlates with suicidal and impulsive-aggressive behavior. Arch Gen Psychiatry 1989;46:587-599.
21. 3H-Paroxetine binding in the platelet. Arch Gen Psychiatry 1996;53:531-536.
22. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodologic study. Arch Gen Psychiatry 1982;39:879-883.
23. Klein DN, Ouimette PC, Kelly HS, Ferro T, Riso LP. Test-retest reliability of a team consensus best-estimate diagnoses of axis I and II disorders in a family study. Am J Psychiatry 1994;151:1043-1047.
24. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia. New York, NY: NY State Psychiatric Institute, 1978.
25. Pfohl B, Zimmerman M. Structured Interview for DSM-III-R Personality Disorders. Iowa City, IA: University of Iowa College of Medicine, 1989.
26. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-HIAA concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983;33:2609-2614.
27. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, Herbert JL, Bernstein DP. Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 1991;3:S44-S51.
28. Coccaro EF, Berman ME, Kavoussi RJ. Assessment of life history of aggression: Development and psychometric characteristics. Psychiatry Res 1997;73:147-157.
29. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957;21:343-348.
30. Eysenck SBG, Eysenck HJ. The place of impulsiveness in a dimensional system of personality discription. Br J Soc Clin Psychol 1977;16:57-68.
31. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 1995;51:768-774.
32. Guy W. ECDEU Manual for Psychopharmacology. Washington, DC: Superintendent of Documents, US Government Printing Office; US Department of Health, Education, and Welfare publication ADM 76-338;1976.
33. O'Sullivan RL, Fava M, Agustin C, Baer L, Rosenbaum JF. Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatr Scand 1997;95:379-384.
34. Spielberger CD. Manual for the State-Trait Anxiety Inventory: STAI (Form Y). Palo Alto, CA: Consulting Psychologists Press, 1983.
35. Horesh N, Rolnick T, Iancu I, Dannon P, Lepkifer E, Apter A, et al. Anger, impulsivity and suicide risk. Psychother Psychosom 1997;66:92-96.
36. First MB, Spitzer RL, Williams JBW. Exclusionary principles and the comorbidity of psychiatric diagnoses: A historical review and implications for the future. In: Maser JD, Cloninger CR (eds): Comorbidity of Mood and Anxiety Disorders, Washington, DC: American Psychiatric Press, 1990:83-109.
37. Widiger TA. Generalized social phobia versus avoidant personality disorder: A commentary on three studies. J Abnorm Psychol 1992;101:340-343.
38. Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, et al. Aggression, suicide, and serotonin: Relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741-746.
39. Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 1990;28:325-338.
40. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy: Evidence for subsensitivity of central serotonergic function. Br J Psychiatry 1992;160:643-646.
41. Silverman JM, Pinkham L, Horvath TB, Coccaro EF, Klar HM, Schear S, et al. Affective and impulsive personality disorder traits in the relatives of borderline personality disorder. Am J Psychiatry 1991;148:1378-1385.
42. Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO. Borderline and schizotypal personality disorders treated with low-dose thiothixine versus placebo. Arch Gen Psychiatry 1986;43:680-686.
43. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: Alprazolam, carbamazepine, trofluroperazine, and tranycypromine. Arch Gen Psychiatry 1988;45: 111-119.
44. Soloff PH, George A, Nathan RS, Schulz PM, Cornelius JR, Herring J, et al. Amitriptyline versus haloperidol in borderlines: Final outcomes and predictors of response. J Clin Psychopharmacol 1989;9:238-246.
45. Soloff PH, Cornelius JR, George A, Nathan RS, Schulz PM, Perel JM, et al. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50: 377-385.
46. Barratt ES, Stanford MS, Felthous AR, Kent TA. The effects of phenytoin on impulsive and premeditated aggression: Acontrolled study. J Clin Psychopharmacol 1997;17:341-349.
47. Bradford J, Geller J, Lesieur HR, Rosenthal R, Wise M. Impulse control disorders. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook, Vol. II. Washington, DC: American Psychiatric Press, 1994:1007-1031.